- My Forums
- Tiger Rant
- LSU Recruiting
- SEC Rant
- Saints Talk
- Pelicans Talk
- More Sports Board
- Fantasy Sports
- Golf Board
- Soccer Board
- O-T Lounge
- Tech Board
- Home/Garden Board
- Outdoor Board
- Health/Fitness Board
- Movie/TV Board
- Book Board
- Music Board
- Political Talk
- Money Talk
- Fark Board
- Gaming Board
- Travel Board
- Food/Drink Board
- Ticket Exchange
- TD Help Board
Customize My Forums- View All Forums
- Show Left Links
- Topic Sort Options
- Trending Topics
- Recent Topics
- Active Topics
Started By
Message
0
Posted on 5/7/21 at 3:54 pm to redfishfan
quote:
90% of medicaid patients now covered and that the vast majority of LN patients are on medicaid programs.
This is true about the majority of lupus patients.
It sounded like he said "90% of Medicaid lives" were covered. Regardless, I believe this is HUGE for the success of Lupkynis.
Retail investors overreacted as they predictably do. I agree with everything you said about the Q1 rollout logistics and projections in your previous statement.
3870 shares strong and counting...
Posted on 5/10/21 at 10:44 am to molsusports
quote:
The Lancet is a high impact journal. They just published a very positive study RE: Voc and AUPH.
Posted on 5/10/21 at 11:53 am to molsusports
I can’t help myself. Bought more this am. The damn patent is worth more than the current value of the company.
Posted on 5/10/21 at 3:23 pm to redfishfan
i bought more too. Not sure why this has been so negative.
Posted on 5/11/21 at 1:27 pm to FMtTXtiger
The number of shares traded daily continues to surprise me.
Posted on 5/11/21 at 1:30 pm to molsusports
What’s up with this price pop?
Posted on 5/11/21 at 1:38 pm to CorkRockingham
quote:
What’s up with this price pop?
Correction from overreaction to poor sales numbers? BO rumors?
Posted on 5/11/21 at 1:59 pm to wally
Correction probably.
Retail bailing this early was an opportunity for others. The Lancet article is also big for getting the word out that this should become the standard of care.
AUPH can fail but I feel good about their chances.
Retail bailing this early was an opportunity for others. The Lancet article is also big for getting the word out that this should become the standard of care.
AUPH can fail but I feel good about their chances.
Posted on 5/11/21 at 2:01 pm to wally
quote:
Correction from overreaction to poor sales numbers?
My thoughts as well. Isn't the company doing a study on something covid related? And does anybody know when that study will be complete?
Posted on 5/11/21 at 2:10 pm to wally
quote:Certainly one of the two.
Correction from overreaction to poor sales numbers? BO rumors?
Posted on 5/11/21 at 3:04 pm to bayoubengals88
That held up well.
-5% premarket?
-5% premarket?
Posted on 5/12/21 at 3:37 pm to bayoubengals88
Good day.
Greenleaf, CEO, bought 5,125 shares and another insider Jill Leversage bought 2,500 shares.
Some AH market action going on too.
and WSJ chatting about buyout rumors...
edit: Another insider buy ex vp of internal operations bought 9,900 shares.
Greenleaf, CEO, bought 5,125 shares and another insider Jill Leversage bought 2,500 shares.
Some AH market action going on too.
and WSJ chatting about buyout rumors...
edit: Another insider buy ex vp of internal operations bought 9,900 shares.
This post was edited on 5/12/21 at 3:51 pm
Posted on 5/12/21 at 3:46 pm to bayoubengals88
quote:Most notably a 20k share buy at 11.96
Some AH market action going on too.
Value - $239,200
Posted on 5/12/21 at 4:15 pm to bayoubengals88
Damn. Weird.
Posted on 5/12/21 at 4:22 pm to bayoubengals88
not surprising to see it fill that ridiculous gap down after earnings.. question is what will it do after?
also apparently the FDA 'accidentally' revealed that the Aurora 2 ongoing/long-term use trial shows that Lupkynis does NOT cause kidney filtration issues beyond 27+ months... which was pretty much the only benefit of using Benlysta over Lupkynis
LINK
also apparently the FDA 'accidentally' revealed that the Aurora 2 ongoing/long-term use trial shows that Lupkynis does NOT cause kidney filtration issues beyond 27+ months... which was pretty much the only benefit of using Benlysta over Lupkynis
LINK
This post was edited on 5/12/21 at 4:33 pm
Posted on 5/12/21 at 4:48 pm to jmcwhrter
So, to the moon tomorrow?
Need some AUPH green charts in my life
Need some AUPH green charts in my life
Posted on 5/12/21 at 5:18 pm to jmcwhrter
quote:That's pretty significant news. Could be the reason behind above average AH?
also apparently the FDA 'accidentally' revealed that the Aurora 2 ongoing/long-term use trial shows that Lupkynis does NOT cause kidney filtration issues beyond 27+ months... which was pretty much the only benefit of using Benlysta over Lupkynis
Posted on 5/12/21 at 9:33 pm to bayoubengals88
quote:
Could be the reason behind above average AH?
Didn't think AH pretty much retrace? I didn't see the volume..
Page 75 of 167
Popular
Back to top
Follow TigerDroppings for LSU Football News